IRIS UniCatt

Petrillo, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.005
EU - Europa 2.455
AS - Asia 2.272
SA - Sud America 382
AF - Africa 66
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 8.193
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.938
SG - Singapore 1.146
DE - Germania 978
CN - Cina 510
SE - Svezia 351
BR - Brasile 307
FR - Francia 223
IT - Italia 209
VN - Vietnam 192
UA - Ucraina 160
GB - Regno Unito 123
IE - Irlanda 102
PL - Polonia 90
IN - India 87
RU - Federazione Russa 66
ID - Indonesia 65
FI - Finlandia 54
TR - Turchia 47
CA - Canada 34
HK - Hong Kong 34
JP - Giappone 31
BD - Bangladesh 27
AR - Argentina 24
IQ - Iraq 21
BE - Belgio 20
MX - Messico 18
CI - Costa d'Avorio 15
ZA - Sudafrica 15
NL - Olanda 12
UZ - Uzbekistan 12
EC - Ecuador 11
ES - Italia 11
SA - Arabia Saudita 11
MA - Marocco 10
IR - Iran 9
PH - Filippine 9
PK - Pakistan 9
CL - Cile 8
KE - Kenya 8
CH - Svizzera 7
CO - Colombia 7
PE - Perù 7
PY - Paraguay 7
VE - Venezuela 7
JO - Giordania 6
KR - Corea 6
KZ - Kazakistan 6
TN - Tunisia 6
AT - Austria 5
EG - Egitto 5
AU - Australia 4
HU - Ungheria 4
LT - Lituania 4
LV - Lettonia 4
NO - Norvegia 4
TJ - Tagikistan 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
EU - Europa 3
HN - Honduras 3
IL - Israele 3
JM - Giamaica 3
MY - Malesia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PA - Panama 3
PS - Palestinian Territory 3
RO - Romania 3
TW - Taiwan 3
UY - Uruguay 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
AZ - Azerbaigian 2
BH - Bahrain 2
BY - Bielorussia 2
CY - Cipro 2
CZ - Repubblica Ceca 2
GE - Georgia 2
GR - Grecia 2
IS - Islanda 2
KG - Kirghizistan 2
LB - Libano 2
LU - Lussemburgo 2
MM - Myanmar 2
NG - Nigeria 2
PT - Portogallo 2
TH - Thailandia 2
A1 - Anonimo 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 8.180
Salva come PNG Salva come JPEG
Città #
Singapore 688
Chandler 568
San Jose 345
Ashburn 251
Jacksonville 117
Beijing 112
Dublin 102
San Mateo 100
Warsaw 79
New York 78
Nürnberg 74
Nanjing 73
Wilmington 73
Los Angeles 68
Ann Arbor 66
Jakarta 62
Lauterbourg 53
Dearborn 52
Hanoi 50
Marseille 49
Ho Chi Minh City 47
Boston 45
Frankfurt am Main 39
Houston 39
Cattolica 35
Izmir 35
Munich 32
Hong Kong 30
Moscow 30
Lawrence 29
São Paulo 29
Tokyo 29
Buffalo 28
Dallas 28
Princeton 27
Rome 27
Chicago 23
Paris 23
Seattle 23
Brussels 20
Hangzhou 20
Redwood City 20
Hefei 17
Kunming 17
Santa Clara 17
Boardman 16
Lancaster 16
Abidjan 15
Fairfield 15
Helsinki 15
Milan 15
Mountain View 15
Changsha 14
Nanchang 14
Norwalk 14
Shanghai 14
Tianjin 13
Woodbridge 13
Bremen 12
Da Nang 12
Haiphong 12
Hebei 12
Leawood 12
London 12
Shenyang 12
Tashkent 12
University Park 12
Atlanta 11
Council Bluffs 11
Brooklyn 10
Nuremberg 10
Phoenix 10
Denver 9
Detroit 9
Dhaka 9
Düsseldorf 9
Falls Church 9
Guangzhou 9
Belo Horizonte 8
Brasília 8
Chennai 8
Hyderabad 8
Jinan 8
Johannesburg 8
Montreal 8
Orem 8
Redmond 8
Toronto 8
Baghdad 7
Bucchianico 7
Jiaxing 7
Lima 7
Manchester 7
San Francisco 7
Amsterdam 6
Can Tho 6
Edinburgh 6
Nairobi 6
Pasig 6
Quito 6
Totale 4.330
Salva come PNG Salva come JPEG
Nome #
Prognostic role of topoisomerase-IIalpha in advanced ovarian cancer patients 310
Evaluation of quality of life and emotional distress in endometrial cancer patients: A 2-year prospective, longitudinal study 239
Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: long-term results 234
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 231
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study 211
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 190
Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: A retrospective analysis 189
Prognostic role of Ca125 response criteria and RECIST criteria: analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancer. 184
Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradiotherapy 182
A complete pathological response to treatment in a young patient with locally advanced minimal deviation adenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 181
Influence of Intraperitoneal Dissemination Assessed by Laparoscopy on Prognosis of Advanced Ovarian Cancer: An Exploratory Analysis of a Single-Institution Experience 178
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 177
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 167
Incidence and predictive factors for complications after uterine leiomyoma embolization 167
Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study 160
Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study 156
Secondary malignancies of the uterine cervix: a potential diagnostic pitfall 155
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsie 155
Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: A case-control study on survival in patients with two year follow-up 154
Minimally invasive versus standard laparotomic interval debulking surgery in ovarian neoplasm: A single-institution retrospective case-control study 153
Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients 150
Non-catalytic region of tyrosine kinase adaptor protein 2 (NCK2) pathways as factor promoting aggressiveness in ovarian cancer 148
Identification and antitumor activity of a novel inhibitor of the NIMA-related kinase NEK6 146
Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma 145
Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis 142
The relevance of prelamin A and RAD51 as molecular biomarkers in cervical cancer 141
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 138
Preoperative serum human epididymis protein 4 levels in early stage endometrial cancer: A prospective study 136
A combined ANXA2-NDRG1-STAT1 gene signature predicts response to chemoradiotherapy in cervical cancer 133
Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: utility of a scoring system to predict outcomes 133
Targeting the hallmarks of ovarian cancer: The big picture 132
Fertility-sparing surgery in ovarian cancer extended beyond the ovaries: a case report and review of the literature 130
FOXL2 molecular status in adult granulosa cell tumors of the ovary: A study of primary and metastatic cases 130
Laparoscopic En Bloc Right Diaphragmatic Peritonectomy for Diaphragmatic Endometriosis According to the Sugarbaker Technique 130
Preoperative Anti-Class III β-Tubulin Antibodies As Relevant Clinical Biomarkers in Ovarian Cancer 129
Ovarian low and high grade serous carcinomas: hidden divergent features in the tumor microenvironment 125
Restructuring surgical training after COVID-19 pandemic: A nationwide survey on the Italian scenario on behalf of the Italian polyspecialistic young surgeons society (SPIGC) 124
Time trade-off procedure for measuring health utilities loss with human papillomavirus-induced diseases: a multicenter, retrospective, observational pilot study in Italy 124
Uncovering the role of nuclear Lysyl oxidase (LOX) in advanced high grade serous ovarian cancer 123
Robotic Total Mesometrial Resection versus Laparoscopic Total Mesometrial Resection in Early Cervical Cancer: A Case-Control Study 115
Polarisation of Tumor-Associated Macrophages toward M2 Phenotype Correlates with Poor Response to Chemoradiation and Reduced Survival in Patients with Locally Advanced Cervical Cancer. 114
Robotic Versus Laparoscopic Staging for Early Ovarian Cancer: A Case Matched Control Study 111
Incidence, predictors and clinical outcome of pancreatic fistula in patients receiving splenectomy for advanced or recurrent ovarian cancer: a large multicentric experience 109
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 108
Survivin protein as predictor of pathologic response in patients with locally advanced cervical cancer treated with chemoradiation followed by radical surgery 106
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsies 105
Role of extracellular vesicles in epithelial ovarian cancer: A systematic review 104
Self-Reported Long-Term Autonomic Function After Laparoscopic Total Mesometrial Resection for Early-Stage Cervical Cancer: A Multicentric Study 103
Secondary cytoreduction in ovarian cancer: who really benefits? 98
Laparoscopic laterally extended endopelvic resection procedure for gynecological malignancies 97
Neoadjuvant Chemotherapy Followed by Maintenance Therapy With or Without Bevacizumab in Unresectable High-Grade Serous Ovarian Cancer: A Case-Control Study 96
Long-Term Survival for Platinum-Sensitive Recurrent Ovarian Cancer Patients Treated with Secondary Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC) 93
Systematic Review of Cytoreductive Surgery and Bevacizumab-Containing Chemotherapy in Advanced Ovarian Cancer: Focus on Safety 93
Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study 91
The safety of bevazicumab for the treatment of ovarian cancer 90
Cytoreductive surgery plus platinum-based hyperthermic intraperitoneal chemotherapy in epithelial ovarian cancer: A promising integrated approach to improve locoregional control 82
Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective study 80
RE: Pattern of and reason for postoperative residual disease in patients with advanced ovarian cancer following upfront radical debulking surgery 75
Simple hysterectomy versus radical hysterectomy in early-stage cervical cancer: A systematic review and meta-analysis 49
Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers 43
Sentinel node mapping, sentinel node mapping plus back-up lymphadenectomy, and lymphadenectomy in Early-sTage cERvical caNcer scheduled for fertilItY-sparing approach: The ETERNITY project 24
Totale 8.318
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.152
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.152
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 0 0 0 0 9
2021/2022618 52 25 11 43 35 25 10 98 40 57 92 130
2022/20231.263 154 203 118 225 53 171 66 75 141 11 28 18
2023/2024500 28 142 8 22 11 73 41 13 9 30 59 64
2024/20251.006 25 26 85 45 105 43 21 36 177 81 190 172
2025/20262.764 398 69 104 260 597 153 515 139 228 198 68 35
Totale 8.318